All In Biotech

Drug Trial Radar · NCT02358993

Short-course Methenamine Hippurate for Prevention of Post-operative UTI

The Efficacy and Cost-effectiveness of a 24-hour Course of metheNamine Hippurate for Preventing Post-Operative Urinary Tract Infection

Last checked: Nov 19, 2026Latest source record: Feb 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 201 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

201

Actual

Start

Dec 2014

Primary completion

Sep 30, 2020

Study completion Sep 30, 2020

Sponsor

Lead sponsor
University of PennsylvaniaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 9, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Prevention
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The investigators will determine the efficacy of an innovative short regimen of methenamine hippurate on prevention of post-operative UTI in patients requiring short-term catheterization after pelvic reconstructive surgery through a single-blind, randomized controlled trial. Primary outcome will be the rate of symptomatic UTI within 3 weeks of catheter removal. The investigators will study cost-effectiveness, antibiotic resistance profiles, and adverse drug effects. Findings may reduce antibiotic use and nosocomial UTIs.

Conditions

  • Urinary Tract Infections
  • Catheter-Related Infections

Interventions

  • methenamine hippurateDrug

    A urinary antiseptic used for prevention of UTI

  • CiprofloxacinDrug

    An antibiotic used for treatment and prevention of UTI

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment of Clinically Suspected UTI - Using Intent to Treat AnalysisTime frame: 3 weeks post-operative
  2. Treatment of Clinically Suspected UTI - Per ProtocolTime frame: 3 weeks post-operative

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania

  • Penn Presbyterian Medical Center

    Philadelphia, Pennsylvania

  • Pennsylvania Hospital

    Philadelphia, Pennsylvania

  • Chestnut Hill Hospital

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.